Reports Q revenue $137.9M, consensus $129.26M.Net income was $3.2M for the fourth quarter of 2022, as compared to a loss of $2.4M in the corresponding prior year period. The diluted income per share for the fourth quarter of 2022 was $ 10c, as compared to the diluted loss per share of 9c in the prior year period. "We are pleased with our strong performance in the fourth quarter and full year 2022. Our growth in the fourth quarter, as well as for the year, was primarily driven by higher utilization at existing centers and the addition of 61 newU.S. implanting centers and 16 new U.S. sales territories. With significant momentum and many accomplishments throughout our business, we are proud to achieve our first profitable quarter," said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. "Given our strong performance in 2022, we are providing 2023 revenue guidance of between $560 million to $570 million, an increase of 37% to 40% year-over-year.""We completed several important milestones in 2022 including an expanded label for full-body MRI compatibility, the commercial launches of our Bluetooth(R)-enabled patient remote and our silicone-based stimulation and sensing leads, the FDA submission of our SleepSync programmer, and important indication expansions for Pediatric Down Syndrome and higher AHI and BMI. We completed enrollment of 300 patients in our PREDICTOR study which aims to remove the drug-induced sleep endoscopy requirement for most patients with BMI under 32. We also made strategic investments in EnsoData and Ognomy and initiated a pilot of a digital scheduling tool to facilitate and streamline patient access to care through our Advisor Care Program," concluded Mr. Herbert.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on INSP:
- Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
- Inspire Medical price target raised to $310 from $308 at Truist
- CVRx initiated with a Buy at Lake Street
- Inspire Medical price target raised to $300 from $285 at Piper Sandler
- Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023